These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11169602)

  • 1. Simulation study and implementation of the tests based on weighted Turnbull's estimators for interval-censored data.
    Chi Y
    Stat Med; 2001 Jan; 20(2):281-94. PubMed ID: 11169602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing several score tests for interval censored data.
    Fay MP
    Stat Med; 1999 Feb; 18(3):273-85. PubMed ID: 10070674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-sample test for stochastic ordering with interval-censored data.
    Petroni GR; Wolfe RA
    Biometrics; 1994 Mar; 50(1):77-87. PubMed ID: 8086617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival distributions in clinical trials: A practical guidance.
    Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
    Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-sample censored-data rank test for acceleration.
    Breslow NE; Edler L; Berger J
    Biometrics; 1984 Dec; 40(4):1049-62. PubMed ID: 6534408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A generalized log-rank test for interval-censored failure time data via multiple imputation.
    Huang J; Lee C; Yu Q
    Stat Med; 2008 Jul; 27(17):3217-26. PubMed ID: 18254128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized two-stage optimal design for interval-censored data.
    Shan G
    J Biopharm Stat; 2022 Mar; 32(2):298-307. PubMed ID: 34890525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unobserved covariates in the two-sample comparison of survival times: a maximum efficiency robust test.
    Broët P; Moreau T; Lellouch J; Asselain B
    Stat Med; 1999 Jul; 18(14):1791-800; discussion 1801. PubMed ID: 10407249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
    Rauch G; Brannath W; Brückner M; Kieser M
    Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A generalization of Turnbull's estimator for nonparametric estimation of the conditional survival function with interval-censored data.
    Dehghan MH; Duchesne T
    Lifetime Data Anal; 2011 Apr; 17(2):234-55. PubMed ID: 20544280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted logrank tests for interval censored data when assessment times depend on treatment.
    Fay MP; Shih JH
    Stat Med; 2012 Dec; 31(28):3760-72. PubMed ID: 22786795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
    Gong Q; Fang L
    Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariate adjustment for non-parametric tests for censored survival data.
    Li Z
    Stat Med; 2001 Jun; 20(12):1843-53. PubMed ID: 11406845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis for survival data under order restrictions with a modified logrank test.
    Liu PY; Tsai WY; Wolf M
    Stat Med; 1998 Jul; 17(13):1469-79. PubMed ID: 9695192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method of sample size calculation for unequal-sample-size designs that use the logrank or t-test.
    Hsieh FY
    Stat Med; 1987; 6(5):577-81. PubMed ID: 3659667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust semi-parametric warping estimator of the survivor function with an application to two-group comparisons.
    Hutson AD
    Stat Methods Med Res; 2018 Feb; 27(2):384-397. PubMed ID: 26988931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivor function estimators under group sequential monitoring based on the logrank statistic.
    Gorfine M
    Lifetime Data Anal; 2003 Jun; 9(2):175-93. PubMed ID: 12735495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.